title: Reply to Scagnolari et al.
authors.affiliation: Institute for Therapeutic Innovation, Department of Medicine, University of Florida, Orlando.
authors.forename: Ashley N
authors.initials: AN
authors.lastname: Brown
authors.affiliation: Institute for Therapeutic Innovation, Department of Medicine, University of Florida, Orlando.
authors.forename: Karen M
authors.initials: KM
authors.lastname: Gallegos
authors.affiliation: Department of Biomedical Engineering, University of Southern California, Los Angeles.
authors.forename: David Z
authors.initials: DZ
authors.lastname: D'Argenio
authors.affiliation: Institute for Therapeutic Innovation, Department of Medicine, University of Florida, Orlando.
authors.forename: George L
authors.initials: GL
authors.lastname: Drusano
mesh_terms: D000998:Antiviral Agents; D002646:Chikungunya virus; D007372:Interferons; D012254:Ribavirin
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons